Shots:
- The CVMP has recommended Nobivac L6 & Nobivac LoVo L6 for the active immunization of dogs against leptospirosis; EC’s decision expected by Q3’25
- The vaccine protects against 6 Leptospira serovars: Canicola, Copenhageni, Bratislava, Bananal/Lianguang, Icterohaemorrhagiae, & Grippotyphosa, preventing mortality, renal carriage, renal lesions, & urinary excretion while reducing infection & clinical signs
- Nobivac L6 is administered as 2 doses in dogs with an interval of 4wks., with the first dose between 6–9wks. of age & the second between 10–13wks. It can be co-administered with Nobivac Rabies, & annual revaccination requires a single dose
Ref: Merck Animal Health | Image: Merck Animal Health| Press Release
Related News:- Merck Animal Health’s Mometamax Single Receives the US FDA’s Approval to Treat Dogs with Otitis Externa
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
